Insphero company
NettetTogether with our partners in academia and industry, InSphero advances drug discovery and our understanding of healthy and diseased human biology pioneering the 3D in … 3D InSight™ Microtissues are delivered to laboratories worldwide in assay-ready in … InSphero assay-ready 3D InSight™ Tumor Microtissues are designed to simplify … Our Solutions for Diabetes Drug Testing. The homogeneous cellular composition, … 3D InSight™ Human Liver Disease Discovery Platform models use … Read InSphero's white papers based on 3D microtissues for drug discovery & … Select from assay-ready 3D tumor models and tumor/stromal models derived from … InSphero CEO and co-founder, Jan Lichtenberg, brings extensive … InSphero's Services: Early compound de-risking and drug discovery decisions … NettetInSphero AG is a Business Services, Biotechnology Research, and Biotechnology company located in Schlieren, Zurich with $13.00 Million in revenue and 80 ... Services, supported by a comprehensive panel of 3D-optimized culture media, assay protocols, and imaging solutions. InSphero’s technologies drive significant findings in peer ...
Insphero company
Did you know?
NettetFunding. InSphero has raised a total of $35.2M in funding over 9 rounds. Their latest funding was raised on Mar 31, 2024 from a Venture - Series Unknown round. InSphero … NettetInsphero Inc. Insphero Inc was founded in 2013. The company's line of business includes the manufacturing of medical, surgical, ophthalmic, and veterinary instruments …
NettetDescription. Provider of 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing. The company's technology helps identify drugs and toxic liabilities with predictive power at early development stages, enabling pharmaceutical and biotechnological ... NettetSenior Application Scientist. InSphero. Sep 2016 - Jan 20244 years 5 months. I work with scientists throughout the US, who focus on liver …
Nettet1. des. 2024 · InSphero is a Swiss-based biotech company that has been perfecting 3D cell-based drug discovery platforms and scaffold-free 3D Organ-on-a-Chip technologies for more than 10 years. The company’s strategic partnering model is based on multi-tiered, custom programs with pharma, biotech and academic organizations and led to … NettetInSphero sets the standard for 3D cell culture in vitro testing for novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide …
Nettet3. des. 2024 · 横河電機株式会社は、創薬における薬理・安全性試験のために最適化された、in vitro三次元培養モデル（3D in vitroモデル）技術のパイオニアであるInSphero AG（インスフェロ）と、ハイコンテントアナリシス（HCA）における薬効や安全性評価手法の確立と推進を目的として、パートナーシップ契約を ...
Nettet13. aug. 2024 · Image courtesy of Corning Life Sciences. Drug screening with organoids typically involves lower density plates compared to 2D screens; for example, rarely will a 1536 well plate be used. Corning offers Matrigel matrix 3D plates as a ready-to-use option for high throughput, as well as a Matrigel formulation designed for use with organoids. cyrano de bergerac playhouseNettetDescription. Provider of 3D-cell-based assay solutions and scaffold-free 3D organ-on-a-chip technology designed to deliver biologically relevant insights for in vitro testing. The … binary tree using pythonNettet2 dager siden · Insphero AG, a pioneer in 3D spheroid and cell-based assays in pharmaceutical drug discovery and safety testing, has raised an eight-figure amount in its latest funding round. InSphero will utilize the proceeds to commercialize its cryo-preservation technology to enable further growth and scalability. Zeiss Ventures is … binary tree using recursion